First Page | Meta Content | |
---|---|---|
Document Date: 2015-03-16 01:05:15Open Document File Size: 620,16 KBShare Result on FacebookCompanyVertex Pharmaceuticals (Australia) Pty Ltd. / The PBAC / /CountryAustralia / /CurrencyUSD / /EventFDA Phase / Reorganization / /IndustryTermtreatment of cystic fibrosis / /MedicalConditionpulmonary / pulmonary exacerbation Absolute change / cystic fibrosis transmembrane conductance regulator / cystic fibrosis / /MedicalTreatmentantibiotics / /PositionMajor / /ProductMeeting 6.11 IVACAFTOR Tablet / IVACAFTOR Tablet / FEV1 / ivacaftor / /PublishedMediumThe Commentary / /RadioStationCFTR / /Technologysubmission Trial ID Protocol / /SocialTag |